Taste and Smell Impairment in Critically Ill COVID-19 Patients

Sponsor
Pinar Ay Sayin (Other)
Overall Status
Completed
CT.gov ID
NCT04532632
Collaborator
(none)
40
1
1.2
32

Study Details

Study Description

Brief Summary

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    40 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Taste and Smell Impairment in Critically Ill COVID-19 Patients
    Actual Study Start Date :
    Sep 1, 2020
    Actual Primary Completion Date :
    Oct 1, 2020
    Actual Study Completion Date :
    Oct 9, 2020

    Outcome Measures

    Primary Outcome Measures

    1. taste and smell impairment [up to 3 months]

      incidence of taste and smell impairment in critically ill subjects

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults between the ages of 18-80

    • Agree to participate in the study

    • Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

    Exclusion Criteria:
    • Pre-existing smell and taste impairment

    • The patients have no enough cooperation to answer the questionnaire

    • Having additional diseases such as dementia and Alzheimer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sisli Etfal Research and Training Hospital Istanbul Turkey 34371

    Sponsors and Collaborators

    • Pinar Ay Sayin

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Pinar Ay Sayin, specialist medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT04532632
    Other Study ID Numbers:
    • 3334-02
    First Posted:
    Aug 31, 2020
    Last Update Posted:
    Nov 10, 2020
    Last Verified:
    Nov 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pinar Ay Sayin, specialist medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 10, 2020